Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

CUSIP: 98943L107

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 7 signals
Share change
-1,740,473
Put/Call ratio
0%
SEC-reported price per share
$21.66
Number of holders
116
Value change
-$54,003,564
Number of buys
65
Open additional details 1 more signal available
Number of sells
52
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
72,096,078

Security key

98943L107

Report period

Q3 2022

Institutions

116

Top holders

10

Ownership snapshot

Top reported holders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Matrix Capital Management...
Disclosed value leader
Matrix Capital Management...
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Quick read

Matrix Capital Management Company, LP leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Matrix Capital Management Company, LP's linked filing trail.
Comparable ownership Top 5
Matrix Capital Management Company... 13%
FMR LLC 11%
VANGUARD GROUP INC 6.2%
PRICE T ROWE ASSOCIATES INC /MD/ 6%
Avidity Partners Management LP 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Matrix Capital Management Company, LP
13F
Company
13F
13%
$258,519,000
9,199,973 shares
30 Jun 2022
FMR LLC
13F
Company
13F
11%
$218,510,000
7,776,168 shares
30 Jun 2022
VANGUARD GROUP INC
13F
Company
13F
6.2%
$126,234,000
4,492,335 shares
30 Jun 2022
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
6%
$120,789,000
4,298,551 shares
30 Jun 2022
Avidity Partners Management LP
13F
Company
13F
5%
$100,763,000
3,585,881 shares
30 Jun 2022
BlackRock Finance, Inc.
13F
Company
13F
4.5%
$91,074,000
3,241,058 shares
30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
116
Shares
58,811,479
Rows available
116
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
115
Q3 2022 holders
116
Holder diff
1
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .